Near-complete response to low-dose ceritinib in recurrent infantile inflammatory myofibroblastic tumour

BACKGROUND: Infantile inflammatory myofibroblastic tumour (IMT) is rare and the majority are driven by anaplastic lymphoma kinase (ALK) rearrangements. Previous literature on the use of ALK inhibitors in paediatric IMTs is extremely limited with no published literature on the use in infants. Crizoti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ecancermedicalscience
Autors principals: Mittal, Abhenil, Gupta, Aarushi, Rastogi, Sameer, Barwad, Adarsh, Sharma, Swati
Format: Artigo
Idioma:Inglês
Publicat: Cancer Intelligence 2021
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8057779/
https://ncbi.nlm.nih.gov/pubmed/33912240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2021.1215
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars